He, Y. et al. 2024. Feasibility Study of Yuejuwan as an Adjuvant Therapy for Primary Liver Cancer. Journal of Contemporary Medical Practice. 6, 10 (Oct. 2024), 12–16. DOI:https://doi.org/10.53469/jcmp.2024.06(10).03.